PSA Screening Significantly Lowers Prostate Cancer Death Risk, Cochrane Review Confirms
A new Cochrane review reveals that PSA blood testing reduces prostate cancer mortality by a small but significant margin. The findings, based on six m...
A new Cochrane review reveals that PSA blood testing reduces prostate cancer mortality by a small but significant margin. The findings, based on six m...
A large-scale review reveals that daily low-dose aspirin does not significantly lower colorectal cancer risk and may increase bleeding risks. Experts...